title: The Need for Biological Outcomes for Biological Drugs in Psoriatic Arthritis.
authors.affiliation: a.l.tan@leeds.ac.uk.
authors.forename: Ai Lyn
authors.initials: AL
authors.lastname: Tan
authors.affiliation: Professor in Regenerative Medicine, UK National Institute for Health Research Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
authors.forename: Dennis
authors.initials: D
authors.lastname: McGonagle
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D006801:Humans
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents